Rustem F Ismagilov

USPTO Granted Patents = 68 (Patent Applications = 26)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 2,034(Granted Patents)

Forward Citations (Not Self Cited) = 1,864(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Arlington, MA (US) (2004)
Chicago, IL (US) (2005 - 2023)
Pasadena, CA (US) (2017 - 2023)
Altadena, CA (US) (2016 - 2024)

Company Filing History:

37 out of 915

University of Chicago

patents

30 out of 4,547

California Institute of Technology

Talis Biomedical Corporation

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

68 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12448655 - Antibiotic susceptibility of microorganisms and related methods and systems (2025-10-21),

2. 12173363 - Absolute quantification of nucleic acids and related methods and systems (2024-12-24),

3. 12173361 - Rodent model and related device, compositions, methods and systems (2024-12-24),

4. 12157705 - Freeze-cast ceramic membrane for size based filtration (2024-12-03),

5. 12122996 - Device for additive delivery of reagents and related methods and systems (2024-10-22),

6. 12097475 - Microfluidic system (2024-09-24),

7. 11866695 - Methods and systems and related compositions for mixtures separation with a solid matrix (2024-01-09),

8. 11853087 - Microfluidic system (2023-12-26),

9. 11827944 - Antibiotic susceptibility of microorganisms and related compositions, methods and systems (2023-11-28),

10. 11795448 - Purification and detection of analytes (2023-10-24),

11. 11760698 - Freeze-cast ceramic membrane for size based filtration (2023-09-19),

12. 11753635 - Methods and systems and related compositions for mixtures separation with a solid matrix (2023-09-12),

13. 11661577 - Co-incubating confined microbial communities (2023-05-30),

14. 11624062 - Methods and systems for performing single cell analysis of molecules and molecular complexes (2023-04-11),

15. 11542545 - Microfluidic measurements of the response of an organism to a drug (2023-01-03),

Title: Rustem F Ismagilov: Innovating Microfluidic Technologies in Chicago

Introduction:

Rustem F Ismagilov, based in Chicago, IL, is a prolific inventor with an impressive portfolio of 62 patents. His groundbreaking work in microfluidic technologies has significantly impacted the fields of fluid flow management, biochemical reactions, and nucleic acid purification.

Latest Patents:

Among his latest patents is the innovative method and system for separating mixtures through a solid matrix. This technology enables the efficient removal of target compounds, such as nucleic acids, from a mixture, enhancing fluid flow control and analytical processes. Additionally, Ismagilov's microfluidic system facilitates rapid and cost-effective manipulation of reactions on a minute scale, ranging from femtoliters to microliters.

Career Highlights:

Ismagilov has made significant contributions to the University of Chicago and the California Institute of Technology, where his pioneering research has advanced the field of microfluidics. His work underscores a commitment to enhancing analytical techniques and streamlining laboratory processes for improved efficiency and accuracy.

Collaborations:

Throughout his career, Ismagilov has collaborated closely with esteemed colleagues such as Joshua David Tice and Cory John Gerdts. Together, they have explored innovative solutions to complex challenges in microfluidic technology, paving the way for future advancements in analytical chemistry and biological sciences.

Conclusion:

Rustem F Ismagilov's inventive spirit and dedication to advancing microfluidic technologies have established him as a prominent figure in the scientific community. His ongoing pursuit of innovation continues to shape the landscape of analytical chemistry, offering new possibilities for research, discovery, and applications in diverse fields.

This text is generated by artificial intelligence and may not be accurate.